Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiping Chen

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Cell Death & Disease|April 14, 2017
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activityLihui Wang, Xing Liu, Yong Ren, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 19, 2022
CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progressionJieheng Wu, Xinlei Liu, Jiangwei Wu, et al.
International Journal of Cancer|January 19, 2007
Evidence for heritable predisposition to epigenetic silencing of MLH1Huiping Chen, Nicholas P Taylor, Kaisa M Sotamaa, et al.
ACS Nano|February 24, 2026
Engineering Smart Bimetallic Ionic-Site MOF Nanozyme Nanocomposites for Microenvironment-Responsive Dynamic Therapy of Periapical PeriodontitisMeng-Meng Pan, Wei-Hu Ye, Run-Ze Zhang, et al.
Diseases of the Colon and Rectum|July 2, 2005
Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patientsBrian Y Shin, Huiping Chen, Laura S Rozek, et al.
Cell Reports|February 2, 2024
EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axisQiuyue Zhang, Yajie Shi, Sen Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2020
IL-37 Represses the Autoimmunity in Myasthenia Gravis via Directly Targeting Follicular Th and B CellsZhuo Liu, Liwen Zhu, Zhengjuan Lu, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Dose-ranging study of lutein supplementation in persons aged 60 years or olderJulie M Rosenthal, Jonghyeon Kim, Francisco de Monasterio, et al.
Oncogene|November 23, 2022
CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotypeWenfeng Zeng, Lixiong Xiong, Wei Wu, et al.
Nature Immunology|September 30, 2025
Chemotherapy-induced CA-repeat DNA fragments in breast cancer trigger antitumor immune responsesXiaoqian Zhang, Penghan Huang, Huiping Chen, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Cell Death & Disease|April 14, 2017
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activityLihui Wang, Xing Liu, Yong Ren, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 19, 2022
CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progressionJieheng Wu, Xinlei Liu, Jiangwei Wu, et al.
International Journal of Cancer|January 19, 2007
Evidence for heritable predisposition to epigenetic silencing of MLH1Huiping Chen, Nicholas P Taylor, Kaisa M Sotamaa, et al.
ACS Nano|February 24, 2026
Engineering Smart Bimetallic Ionic-Site MOF Nanozyme Nanocomposites for Microenvironment-Responsive Dynamic Therapy of Periapical PeriodontitisMeng-Meng Pan, Wei-Hu Ye, Run-Ze Zhang, et al.
Diseases of the Colon and Rectum|July 2, 2005
Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patientsBrian Y Shin, Huiping Chen, Laura S Rozek, et al.
Cell Reports|February 2, 2024
EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axisQiuyue Zhang, Yajie Shi, Sen Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2020
IL-37 Represses the Autoimmunity in Myasthenia Gravis via Directly Targeting Follicular Th and B CellsZhuo Liu, Liwen Zhu, Zhengjuan Lu, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Dose-ranging study of lutein supplementation in persons aged 60 years or olderJulie M Rosenthal, Jonghyeon Kim, Francisco de Monasterio, et al.
Oncogene|November 23, 2022
CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotypeWenfeng Zeng, Lixiong Xiong, Wei Wu, et al.
Nature Immunology|September 30, 2025
Chemotherapy-induced CA-repeat DNA fragments in breast cancer trigger antitumor immune responsesXiaoqian Zhang, Penghan Huang, Huiping Chen, et al.
Pageof 17